V
VERA THERAPEUTICS INC
NASDAQ: VERA (Vera Therapeutics, Inc.)
最近更新时间: 8小时之前25.94
-2.52 (-8.85%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Vera Therapeutics, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
0.9
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -1.5 |
| 平均 | 0.88 |
|
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 3.97% |
| 机构持股比例 | 112.39% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Avoro Capital Advisors Llc | 30 Jun 2025 | 6,300,000 |
| Kynam Capital Management, Lp | 30 Jun 2025 | 3,426,887 |
| Deerfield Management Company, L.P. | 30 Jun 2025 | 3,348,117 |
| Vestal Point Capital, Lp | 30 Jun 2025 | 3,100,000 |
| Sofinnova Investments, Inc. | 30 Jun 2025 | 2,793,987 |
| Eversept Partners, Lp | 30 Jun 2025 | 2,383,055 |
| Tang Capital Management Llc | 30 Jun 2025 | 1,350,000 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 53.00 (JP Morgan, 104.32%) | 购买 |
| 中 | 50.50 (94.68%) | |
| 低 | 48.00 (B of A Securities, 85.04%) | 购买 |
| 平均值 | 50.50 (94.68%) | |
| 总计 | 2 购买 | |
| 平均价格@调整类型 | 25.12 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| B of A Securities | 16 Oct 2025 | 48.00 (85.04%) | 购买 | 30.51 |
| JP Morgan | 07 Aug 2025 | 53.00 (104.32%) | 购买 | 19.72 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合